Literature DB >> 6980828

Cytolytic T cells activated by H-2-controlled E molecules cross-react with A molecules.

I Vucak, A Juretić, Z A Nagy, J Klein.   

Abstract

Cell-mediated lymphocytotoxicity was generated in four strain combinations differing only by the cell-surface expression of the class II E molecule controlled by the H-2 complex. The four combinations were: B10.D2(R107) anti-B10.A(3R), B10.A(4R) anti-B10.A(2R), B10.GD anti-B10.D2(R101), and B10.S(7R) anti-B10.S(9R). In all four of these combinations, the stimulator expresses E molecules on the cell surface, while the responder does not. The cytolytic T lymphocytes generated in the B10.D2(R107) anti-B10.A(3R) and B10.A(4R) anti-B10.A(2R) combinations reacted not only with the stimulator but also with strains that do not express cell-surface E molecules, in particular, strains carrying the H-2f and H-2q haplotypes. The cross-reactivity with E-negative strains could be blocked by monoclonal antibodies specific for the Af or Aq molecules but not by antibodies recognizing determinants on E or class I (K) molecules. The anti-H-2f cross-reactivity could be inhibited by H-2q cold targets and, reciprocally, the anti-H-2q reactivity could be blocked by H-2f cold targets. These findings are interpreted as indicating that the cytolytic T lymphocytes stimulated by E molecules can recognize and lyse cells lacking E molecules but expressing A molecules. The observed E-A cross-reactivity supports the notion of structural and functional relatedness between the A and E molecules and suggests a common evolutionary origin of the A- and E-encoding loci.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980828     DOI: 10.1007/BF00345911

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  17 in total

1.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

2.  Serological cross-reactivity between products of different Ia loci.

Authors:  P A Lowry; D B Murphy
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  Fine specificity of a proliferating T-cell clone activated by a conformational determinant of the I-Ek molecule.

Authors:  A Pierres; M Pierres
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  Detection of CML determinants associated with H-2 controlled E beta and E alpha chains.

Authors:  A Juretić; Z A Nagy; J Klein
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

5.  Generation of cytotoxic T lymphocytes by the H-2-encoded E molecules.

Authors:  A Juretić; Z A Nagy; J Klein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Clonal analysis of B- and T-cell responses to Ia antigens. I. Topology of epitope regions on I-Ak and I-Ek molecules analyzed with 35 monoclonal alloantibodies.

Authors:  M Pierres; C Devaux; M Dosseto; S Marchetto
Journal:  Immunogenetics       Date:  1981-12       Impact factor: 2.846

7.  Distinct epitopes of Ik gene products identified by monoclonal antibodies.

Authors:  M Pierres; F M Kourilsky; J P Rebouah; M Dosseto; D Caillol
Journal:  Eur J Immunol       Date:  1980-12       Impact factor: 5.532

8.  Histocompatibility antigens controlled by the I region of the murine H-2 complex. II. K/D region compatibility is not required for I-region cell-mediated lymphocytotoxicity.

Authors:  J Klein; C L Chiang; V Hauptfeld
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

9.  Two-gene control of the expression of a murine Ia antigen.

Authors:  P P Jones; D B Murphy; H O McDevitt
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse.

Authors:  H Wagner; D Götze; L Ptschelinzew; M Röllinghoff
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.